Learn about adrenal nodule diagnosis, including clinical documentation and medical coding for adrenal masses, adrenal tumors, and adrenal lesions. Find information on healthcare best practices for identifying and managing an adrenal mass, adrenal tumor, or adrenal lesion. This resource offers guidance on adrenal nodule diagnosis, supporting accurate medical coding and comprehensive clinical documentation.
Also known as
Hyperplasia of adrenal gland
Overgrowth of adrenal gland tissue, often causing nodules.
Benign neoplasm of adrenal gland
Non-cancerous tumors in the adrenal gland.
Malignant neoplasm of adrenal gland
Cancerous tumors of the adrenal gland.
Other general symptoms and signs
Can be used for unspecified adrenal abnormalities if others dont fit.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the adrenal nodule functional (hormone-producing)?
When to use each related code
| Description |
|---|
| Growth in the adrenal gland. Can be benign or cancerous. |
| Benign adrenal tumor producing excess hormones. |
| Non-functioning adrenal adenoma. Usually benign and asymptomatic. |
Missing documentation specifying right, left, or bilateral adrenal nodule impacts coding accuracy and reimbursement.
Incomplete documentation distinguishing benign from malignant adrenal masses affects coding, treatment, and surveillance planning.
Lack of clarity on whether the adrenal nodule is incidental or causing symptoms can lead to coding and clinical management discrepancies.
Q: How can I differentiate between benign and malignant adrenal nodules based on imaging characteristics like size, shape, and CT attenuation values?
A: Differentiating benign from malignant adrenal nodules requires a comprehensive evaluation of imaging characteristics. Size is a crucial factor, with nodules larger than 4 cm warranting closer scrutiny for malignancy. Shape and CT attenuation values also provide important clues. Irregular shapes, heterogeneous enhancement, and high attenuation values (especially >10 Hounsfield Units on non-contrast CT) raise suspicion for malignancy. However, these features are not definitive. Washout rate on contrast-enhanced CT can further aid differentiation, with rapid washout suggesting a benign adenoma. Ultimately, a combination of imaging findings, patient risk factors, and hormonal evaluation is often necessary for accurate characterization. Explore how S10.AI can streamline the analysis of adrenal nodule imaging characteristics for improved diagnostic accuracy.
Q: What is the recommended follow-up imaging protocol for incidentally discovered, non-functioning adrenal nodules based on size and risk factors?
A: The recommended follow-up imaging protocol for incidentally discovered, non-functioning adrenal nodules varies based on size and patient-specific risk factors for malignancy. Small, homogenous nodules (<4 cm) with benign imaging characteristics in low-risk patients may not require follow-up imaging. However, nodules between 4-6 cm should typically undergo repeat imaging within 6-12 months. For nodules >6 cm or those with suspicious features, further evaluation with dedicated adrenal protocol CT or MRI is warranted. Patients with a history of malignancy or endocrine disorders require individualized follow-up strategies. Consider implementing S10.AI's decision support tools for personalized adrenal nodule management based on current guidelines.
Patient presents with concerns regarding a possible adrenal nodule, also referred to as an adrenal mass, adrenal tumor, or adrenal lesion. Review of systems includes detailed inquiry regarding symptoms such as abdominal pain, flank pain, back pain, unexplained weight changes, changes in blood pressure (including hypertension or hypotension), fatigue, and hormonal imbalances. Physical examination findings are documented, including palpation of the abdomen and assessment for any signs of Cushing syndrome, Conn syndrome, or pheochromocytoma. Differential diagnosis includes benign adrenal adenoma, adrenocortical carcinoma, pheochromocytoma, myelolipoma, and metastatic disease. Diagnostic workup may include abdominal ultrasound, CT scan of the adrenal glands with and without contrast, MRI of the adrenal glands, hormonal blood tests (cortisol, aldosterone, renin, catecholamines), and 24-hour urine collection for metanephrines and catecholamines. Management plan is based on imaging characteristics, hormonal evaluation, and patient symptoms. Options include watchful waiting with serial imaging, further biochemical testing, fine-needle aspiration biopsy, or surgical resection (adrenalectomy) for suspicious or symptomatic lesions. Patient education provided regarding the nature of adrenal nodules, potential complications, and the importance of follow-up care. ICD-10 codes (e.g., D35.0, D35.1 depending on laterality and specific diagnosis), CPT codes for procedures (e.g., imaging, biopsy, adrenalectomy) will be assigned based on the final diagnosis and treatment plan. The patient's risk factors, family history, and relevant medical history are documented and considered in the assessment. Referral to endocrinology or surgical oncology may be warranted depending on the final diagnosis and management plan.